Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Account Payables (2016 - 2022)

Historic Change in Account Payables for Abeona Therapeutics (ABEO) over the last 6 years, with Q1 2022 value amounting to -$296000.0.

  • Abeona Therapeutics' Change in Account Payables fell 12085.98% to -$296000.0 in Q1 2022 from the same period last year, while for Jun 2022 it was -$19.6 million, marking a year-over-year decrease of 37282.46%. This contributed to the annual value of -$5.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2022, Abeona Therapeutics' Change in Account Payables is -$296000.0, which was down 12085.98% from -$20.0 million recorded in Q4 2021.
  • Abeona Therapeutics' 5-year Change in Account Payables high stood at $4.5 million for Q3 2018, and its period low was -$20.0 million during Q4 2021.
  • In the last 3 years, Abeona Therapeutics' Change in Account Payables had a median value of $669000.0 in 2021 and averaged -$1.0 million.
  • Examining YoY changes over the last 5 years, Abeona Therapeutics' Change in Account Payables showed a top increase of 38784.81% in 2018 and a maximum decrease of 17668.54% in 2018.
  • Abeona Therapeutics' Change in Account Payables (Quarter) stood at -$273000.0 in 2018, then plummeted by 7226.01% to -$20.0 million in 2021, then soared by 98.52% to -$296000.0 in 2022.
  • Its Change in Account Payables was -$296000.0 in Q1 2022, compared to -$20.0 million in Q4 2021 and $669000.0 in Q3 2021.